Anika Therapeutics Aktie
12,40
EUR
-0,60
EUR
-4,62
%
14,93
USD
+0,27
USD
+1,82
%
Anika Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Anika Therapeutics Aktie Analyse
| 22.02.19 | Anika Therapeutics Neutral | First Analysis Securities | |
| 20.06.18 | Anika Therapeutics Mkt Perform | Barrington Research | |
| 20.06.18 | Anika Therapeutics Equal-Weight | First Analysis Securities | |
| 23.02.18 | Anika Therapeutics Mkt Perform | Barrington Research | |
| 28.08.15 | Anika Therapeutics Equal-Weight | First Analysis Securities |
Werbung
Werbung